A recent "Hands On" article in Urology Times ("Post-prostate biopsy infection: Incidence and preventive steps," July 2011, pages 40-41) included a Figure that contained an error.
A recent "Hands On" article in Urology Times ("Post-prostate biopsy infection: Incidence and preventive steps," July 2011, pages 40-41) included a Figure that contained an error.
The Figure inadvertently transposed the terms "Fluoroquinolone-resistant" and "Fluoroquinolone-sensitive."
For the complete article, which includes the corrected Figure, please see urologytimes.com/HandsOnbiopsyinfection.
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.